This trial will study how the body processes oxycodone when given alone or with nafamostat, an antifungal drug.
6 Primary · 4 Secondary · Reporting Duration: pre-dose, 0.5,1,1.5,2,3,4,6,8,12,16,24,36,48 hours
Experimental Treatment
64 Total Participants · 2 Treatment Groups
Primary Treatment: PF614 solution · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Age 18 - 55 · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: